Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line

This study published in the International Journal of Molecular Sciences investigated the effects of several bioregulatory peptides, including Chonluten (Thr-Glu-Asp-Gly), on the monocyte/macrophage THP-1 cell line — a widely used model for studying innate immune response and inflammation. The researchers evaluated the effects on cell proliferation and modulation of inflammatory pathways, focusing on the response to bacterial lipopolysaccharide (LPS).

The main finding for Chonluten was its ability to inhibit TNF-alpha production (tumor necrosis factor alpha) in monocytes exposed to LPS, a potent pro-inflammatory stimulus that simulates bacterial infection. This inhibition occurred without compromising cell viability, suggesting fine-tuned modulation of the inflammatory response rather than cytotoxicity.

The researchers proposed that Chonluten acts as a natural inducer of TNF tolerance, a phenomenon whereby immune cells become less responsive to repeated inflammatory stimuli — a protective mechanism that prevents excessive inflammation and collateral tissue damage. This type of tolerance is crucial for avoiding the "cytokine storm" observed in conditions such as sepsis and autoimmune diseases.

The study is relevant for two main reasons: first, it demonstrates that peptides of only 4 amino acids can modulate complex immune responses; second, it represents a collaboration between Russian (Khavinson's group) and Italian researchers, broadening the international validation of peptide bioregulators. The results suggest therapeutic potential for Chonluten as an anti-inflammatory agent in conditions of chronic or excessive inflammation.